Apogee Therapeutics (APGE) Other Working Capital Changes (2023 - 2026)

Apogee Therapeutics (APGE) has 4 years of Other Working Capital Changes data on file, last reported at $2.5 million in Q1 2026.

• Quarterly Other Working Capital Changes rose 345.56% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 million (up 5.27% YoY) and the FY2025 annual result came in at $2.1 million, down 65.36% from the prior year.
• Other Working Capital Changes improved to $2.5 million in Q1 2026 per APGE's latest filing, from -$1.6 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $5.7 million in Q3 2025 and bottomed at -$3.7 million in Q4 2023.
• The 4-year median for Other Working Capital Changes is $596000.0 (2024), against an average of $800461.5.
• The widest annual swing landed in 2024, when Other Working Capital Changes tumbled 697.73%; it then soared 345.56% in 2026.
• Tracing APGE's Other Working Capital Changes over 4 years: stood at -$3.7 million in 2023, then soared by 116.23% to $596000.0 in 2024, then tumbled by 375.5% to -$1.6 million in 2025, then jumped by 251.64% to $2.5 million in 2026.
• Per Business Quant, the three latest APGE Other Working Capital Changes figures stand at $2.5 million (Q1 2026), -$1.6 million (Q4 2025), and $5.7 million (Q3 2025).

Peer Comparison